INZY - Inozyme Pharma EPS misses by $1.02
Inozyme Pharma (INZY): Q3 GAAP EPS of -$1.55 misses by $1.02.Cash, cash equivalents and investments of $171.7MPress Release
For further details see:
Inozyme Pharma EPS misses by $1.02Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get INZY Alerts
News, Short Squeeze, Breakout and More Instantly...